Vertex Pharmaceuticals: double bottom and relaunch from base
Vertex Pharmaceuticals weekly technical analysis — fresh buy setup, week 1. Double bottom in the 421 area, bullish MACD crossover, strong support cluster in the 444 area. IQS at 60, medium signal strength — steady trade setup requiring active management.
Vertiv, 3 Weeks Without Confirmation: A Sell Signal That Won't Follow Through
Vertiv weekly technical analysis — sell signal at week 3, no confirmation yet. Trade setup remains inconclusive; performance at -5.5% from inception. Our model flags elevated-risk conditions with the stock 168% above its 200-week moving average.
Valero Energy: model coverage complete, trade runs on trailing stop
Week 23 for Valero Energy: all 3 model time windows completed, +27.5% performance. Residual capital runs on a trailing stop anchored to the weekly Inversion Point. Tough week: -8.6% with sellers at 78%. The daily double bottom in the 230 area is the key level to watch.
Vanguard Dividend Appreciation ETF: mature signal, all 3 model targets already hit
Vanguard Dividend Appreciation ETF buy setup at week 10, +6.2% performance since entry. All 3 statistical targets of our most advanced model have been hit — the trade now moves to residual capital management with a trailing stop on the Inversion Point.
Vanguard Information Technology ETF: Three Targets Hit, Final Window Approaching
Week 9 of a buy trade setup on Vanguard Information Technology ETF: all 3 statistical targets already hit, +19% performance from entry, stop at breakeven. Final model window opens at week 10.
Europe at the highs: 3rd window reached, but resistance holds
Vanguard FTSE Europe ETF · week 10 of a buy setup, all 3 statistical targets of our model already hit. Technical analysis shows weak conviction and a heavily contested resistance zone — trade setup calls for active management, not adding exposure.